Viewing Study NCT00055692


Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2026-04-08 @ 5:53 PM
Study NCT ID: NCT00055692
Status: COMPLETED
Last Update Posted: 2016-02-29
First Post: 2003-03-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Primary Hepatocellular Carcinoma View
None Localized Unresectable Adult Primary Liver Cancer View
None Recurrent Adult Primary Liver Cancer View
Keywords: